Clayton, Australia

Christopher John Hamilton Porter

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Beijing University of Technology, Puretech Lyt, Inc., Seaport Therapeutics, Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher John Hamilton Porter. Retrieved from https://idiyas.com/inventor/christopher-john-hamilton-porter-qzlp1nll

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 9.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Clayton, AU (2022 - 2024)
  • South Melbourne, AU (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Christopher John Hamilton Porter

Introduction

Christopher John Hamilton Porter is an accomplished inventor based in Clayton, Australia. He holds a total of 4 patents that reflect his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing innovative lipid prodrugs aimed at improving therapeutic efficacy.

Latest Patents

Porter's latest patents include groundbreaking inventions such as lymphatic system-directing lipid prodrugs. This invention provides pharmaceutical compositions and methods for producing these prodrugs, which enhance the bioavailability of therapeutic agents. Additionally, he has developed lipid prodrugs of mycophenolic acid, which also aim to improve treatment methods for various diseases and disorders.

Career Highlights

Throughout his career, Porter has worked with notable institutions, including Beijing University of Technology and Puretech Lyt, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Porter has collaborated with several professionals in his field, including Daniel Kenneth Bonner and Ketki Karanam. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Christopher John Hamilton Porter is a notable inventor whose work in lipid prodrugs has the potential to significantly impact pharmaceutical treatments. His innovative approach continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…